Autologous reconstitution of human cancer and immune system in vivo

Juan Fu, Rupashree Sen, David L. Masica, Rachel Karchin, Drew Pardoll, Vonn Walter, D. Neil Hayes, Christine H. Chung, Young J. Kim

Research output: Research - peer-reviewArticle

Abstract

Correlative studies from checkpoint inhibitor trials have indicated that better understanding of human leukocytic trafficking into the human tumor microenvironment can expedite the translation of future immune-oncologic agents. In order to directly characterize signaling pathways that can regulate human leukocytic trafficking into the tumor, we have developed a completely autologous xenotransplantation method to reconstitute the human tumor immune microenvironment in vivo. We were able to genetically mark the engrafted CD34+ bone marrow cells as well as the tumor cells, and follow the endogenous leukocytic infiltration into the autologous tumor. To investigate human tumor intrinsic factors that can potentially regulate the immune cells in our system, we silenced STAT3 signaling in the tumor compartment. As expected, STAT3 signaling suppression in the tumor compartment in these autologously reconstituted humanized mice showed increased tumor infiltrating lymphocytes and reduction of arginase-1 in the stroma, which were associated with slower tumor growth rate. We also used this novel system to characterize human myeloid suppressor cells as well as to screen novel agents that can alter endogenous leukocytic infiltration into the tumor. Taken together, we present a valuable method to study individualized human tumor microenvironments in vivo without confounding allogeneic responses.

LanguageEnglish (US)
Pages2053-2068
Number of pages16
JournalOncotarget
Volume8
Issue number2
DOIs
StatePublished - 2017

Fingerprint

Immune System
Neoplasms
Tumor Microenvironment
Human Trafficking
Tumor-Infiltrating Lymphocytes
Arginase
Heterologous Transplantation
Intrinsic Factor
Myeloid Cells
Bone Marrow Cells
Growth

Keywords

  • Autologous reconstitution
  • Head neck carcinoma
  • Humanized mice
  • Immune response
  • Immunity
  • Immunology and Microbiology Section
  • STAT3
  • Tumor microenvironment

ASJC Scopus subject areas

  • Oncology

Cite this

Fu, J., Sen, R., Masica, D. L., Karchin, R., Pardoll, D., Walter, V., ... Kim, Y. J. (2017). Autologous reconstitution of human cancer and immune system in vivo. Oncotarget, 8(2), 2053-2068. DOI: 10.18632/oncotarget.14026

Autologous reconstitution of human cancer and immune system in vivo. / Fu, Juan; Sen, Rupashree; Masica, David L.; Karchin, Rachel; Pardoll, Drew; Walter, Vonn; Hayes, D. Neil; Chung, Christine H.; Kim, Young J.

In: Oncotarget, Vol. 8, No. 2, 2017, p. 2053-2068.

Research output: Research - peer-reviewArticle

Fu, J, Sen, R, Masica, DL, Karchin, R, Pardoll, D, Walter, V, Hayes, DN, Chung, CH & Kim, YJ 2017, 'Autologous reconstitution of human cancer and immune system in vivo' Oncotarget, vol 8, no. 2, pp. 2053-2068. DOI: 10.18632/oncotarget.14026
Fu J, Sen R, Masica DL, Karchin R, Pardoll D, Walter V et al. Autologous reconstitution of human cancer and immune system in vivo. Oncotarget. 2017;8(2):2053-2068. Available from, DOI: 10.18632/oncotarget.14026
Fu, Juan ; Sen, Rupashree ; Masica, David L. ; Karchin, Rachel ; Pardoll, Drew ; Walter, Vonn ; Hayes, D. Neil ; Chung, Christine H. ; Kim, Young J./ Autologous reconstitution of human cancer and immune system in vivo. In: Oncotarget. 2017 ; Vol. 8, No. 2. pp. 2053-2068
@article{4001bc32015e410f877a9d6aa7bb2c14,
title = "Autologous reconstitution of human cancer and immune system in vivo",
abstract = "Correlative studies from checkpoint inhibitor trials have indicated that better understanding of human leukocytic trafficking into the human tumor microenvironment can expedite the translation of future immune-oncologic agents. In order to directly characterize signaling pathways that can regulate human leukocytic trafficking into the tumor, we have developed a completely autologous xenotransplantation method to reconstitute the human tumor immune microenvironment in vivo. We were able to genetically mark the engrafted CD34+ bone marrow cells as well as the tumor cells, and follow the endogenous leukocytic infiltration into the autologous tumor. To investigate human tumor intrinsic factors that can potentially regulate the immune cells in our system, we silenced STAT3 signaling in the tumor compartment. As expected, STAT3 signaling suppression in the tumor compartment in these autologously reconstituted humanized mice showed increased tumor infiltrating lymphocytes and reduction of arginase-1 in the stroma, which were associated with slower tumor growth rate. We also used this novel system to characterize human myeloid suppressor cells as well as to screen novel agents that can alter endogenous leukocytic infiltration into the tumor. Taken together, we present a valuable method to study individualized human tumor microenvironments in vivo without confounding allogeneic responses.",
keywords = "Autologous reconstitution, Head neck carcinoma, Humanized mice, Immune response, Immunity, Immunology and Microbiology Section, STAT3, Tumor microenvironment",
author = "Juan Fu and Rupashree Sen and Masica, {David L.} and Rachel Karchin and Drew Pardoll and Vonn Walter and Hayes, {D. Neil} and Chung, {Christine H.} and Kim, {Young J.}",
year = "2017",
doi = "10.18632/oncotarget.14026",
volume = "8",
pages = "2053--2068",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "2",

}

TY - JOUR

T1 - Autologous reconstitution of human cancer and immune system in vivo

AU - Fu,Juan

AU - Sen,Rupashree

AU - Masica,David L.

AU - Karchin,Rachel

AU - Pardoll,Drew

AU - Walter,Vonn

AU - Hayes,D. Neil

AU - Chung,Christine H.

AU - Kim,Young J.

PY - 2017

Y1 - 2017

N2 - Correlative studies from checkpoint inhibitor trials have indicated that better understanding of human leukocytic trafficking into the human tumor microenvironment can expedite the translation of future immune-oncologic agents. In order to directly characterize signaling pathways that can regulate human leukocytic trafficking into the tumor, we have developed a completely autologous xenotransplantation method to reconstitute the human tumor immune microenvironment in vivo. We were able to genetically mark the engrafted CD34+ bone marrow cells as well as the tumor cells, and follow the endogenous leukocytic infiltration into the autologous tumor. To investigate human tumor intrinsic factors that can potentially regulate the immune cells in our system, we silenced STAT3 signaling in the tumor compartment. As expected, STAT3 signaling suppression in the tumor compartment in these autologously reconstituted humanized mice showed increased tumor infiltrating lymphocytes and reduction of arginase-1 in the stroma, which were associated with slower tumor growth rate. We also used this novel system to characterize human myeloid suppressor cells as well as to screen novel agents that can alter endogenous leukocytic infiltration into the tumor. Taken together, we present a valuable method to study individualized human tumor microenvironments in vivo without confounding allogeneic responses.

AB - Correlative studies from checkpoint inhibitor trials have indicated that better understanding of human leukocytic trafficking into the human tumor microenvironment can expedite the translation of future immune-oncologic agents. In order to directly characterize signaling pathways that can regulate human leukocytic trafficking into the tumor, we have developed a completely autologous xenotransplantation method to reconstitute the human tumor immune microenvironment in vivo. We were able to genetically mark the engrafted CD34+ bone marrow cells as well as the tumor cells, and follow the endogenous leukocytic infiltration into the autologous tumor. To investigate human tumor intrinsic factors that can potentially regulate the immune cells in our system, we silenced STAT3 signaling in the tumor compartment. As expected, STAT3 signaling suppression in the tumor compartment in these autologously reconstituted humanized mice showed increased tumor infiltrating lymphocytes and reduction of arginase-1 in the stroma, which were associated with slower tumor growth rate. We also used this novel system to characterize human myeloid suppressor cells as well as to screen novel agents that can alter endogenous leukocytic infiltration into the tumor. Taken together, we present a valuable method to study individualized human tumor microenvironments in vivo without confounding allogeneic responses.

KW - Autologous reconstitution

KW - Head neck carcinoma

KW - Humanized mice

KW - Immune response

KW - Immunity

KW - Immunology and Microbiology Section

KW - STAT3

KW - Tumor microenvironment

UR - http://www.scopus.com/inward/record.url?scp=85009739636&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85009739636&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.14026

DO - 10.18632/oncotarget.14026

M3 - Article

VL - 8

SP - 2053

EP - 2068

JO - Oncotarget

T2 - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 2

ER -